Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Pazur A et al. | 2009 | plant, <i>Arabidopsis thaliana</i> (equorin expressing mutant <i>Col0-1 Aeq Cy+</i>) and wild type | magnetic field, 50/60 Hz, DC, static magnetic field | 0.1–65.8 µT |
Gaetani R et al. | 2009 | intact cell/cell culture, cardiospheres and cardiosphere-derived cells | electric field, magnetic field, low frequency, static magnetic field, co-exposure | - |
Belton M et al. | 2009 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | static magnetic field, DC | 100 mT |
Dini L et al. | 2009 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | static magnetic field | 6 mT |
Rozanski C et al. | 2009 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | static magnetic field, DC | 100 mT |
Belton M et al. | 2008 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | static magnetic field | 1–100 mT |
Tenuzzo B et al. | 2006 | intact cell/cell culture, human lymphocytes, mouse thymocytes, FRTL-5 cells (Fischer rat thyroid cells), Hep G2 cells (hepatic transformed cell line), HeLa cell line (human adenocarcinoma cell line), U937 (human leukemic monocyte cell line) and 3 DO cells (T cell hybridoma cell li | static magnetic field | 6 mT |
Salerno S et al. | 2006 | intact cell/cell culture, human lymphocytes | static magnetic field, DC, MRI | 0.5 mT–0.5 T |
Ayrapetyan G et al. | 2005 | isolated bio./chem. substance, physiological solution | static magnetic field | 27 mT |
Chionna A et al. | 2003 | intact cell/cell culture, U937 (human leukemic monocyte cell line) and human lymphocytes | static magnetic field | 6 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.